Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Long-Term Follow-Up Study to Evaluate the Use of the Minder Device to Aid in Treatment After Actionable Event Identification in Patients Diagnosed With Epilepsy.

NCT07110454 is registered in ClinicalTrials.gov with Epiminder America, Inc. as lead sponsor.

NCT NCT07110454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07110454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Long-Term Follow-Up Study to Evaluate the Use of the Minder Device to Aid in Treatment After Actionable Event Identification in Patients Diagnosed With Epilepsy.
Lead sponsor
Epiminder America, Inc.
Phase
Observational
Overall status
Recruiting
Start date
December 23, 2025
Completion date
January 31, 2029
Enrollment
210 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, epilepsy (treatment refractory)